(Total Views: 209)
Posted On: 07/15/2020 11:38:59 AM
Post# of 106809
COPD, OPIOID ADDICTION and CORONAVIRUS / COVID-19 LUNG DAMAGE TREATMENT ?
Recently NCMRD's COPD compound may help reduce life-threatening bronchial and lung inflammation caused by Covid-19 .
https://www.ncmbiotech.com
NCM in the JOURNALl of CANNABIS RESEARCH
https://jcannabisresearch.biomedcentral.com/a...019-0014-9
COPD
https://www.mayoclinic.org/diseases-condition...c-20353679
Recently NCMRD's COPD compound may help reduce life-threatening bronchial and lung inflammation caused by Covid-19 .
https://www.ncmbiotech.com
Quote:
As part of our overall medical cannabis strategy, we are committed to mitigating the opioid epidemic by providing appropriate medical cannabis alternatives
Quote:
PAOG intends to acquire NCM Biotech from Kali-Extracts, Inc. (KALY). NCM Biotech is focused on medical research and the development of treatments derived from its patented cannabis extraction process. See a recent research report on CBD extracts derived from NCM Biotech's patented extraction process:
Look for more details on PAOG's revitalization coming soon. https://finance.yahoo.com/news/paog-announces...00694.html
NCM in the JOURNALl of CANNABIS RESEARCH
https://jcannabisresearch.biomedcentral.com/a...019-0014-9
COPD
https://www.mayoclinic.org/diseases-condition...c-20353679
(0)
(0)
